Hirofumi Mukai

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Topics

Combination Therapy

Randomized Controlled Trial

Positive Breast Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

British journal of cancer

Breast cancer research and treatment

JCO clinical cancer informatics

This page only lists publications with an associated author ORCID identifier.

Publications

Takuji Iwase, Shigehira Saji, Kotaro Iijima, Kenji Higaki, Shoichiro Ohtani, Yasuyuki Sato, Yasuo Hozumi, Yoshie Hasegawa, Yasuhiro Yanagita, Hiroyuki Takei, Maki Tanaka, Hideji Masuoka, Masahiko Tanabe, Chiyomi Egawa, Yoshifumi Komoike, Toshitaka Nakamura, Hiroshi Ohtsu, Hirofumi Mukai
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Takuji Iwase, Shigehira Saji, Kotaro Iijima, Kenji Higaki, Shoichiro Ohtani, Yasuyuki Sato, Yasuo Hozumi, Yoshie Hasegawa, Yasuhiro Yanagita, Hiroyuki Takei, Maki Tanaka, Hideji Masuoka, Masahiko Tanabe, Chiyomi Egawa, Yoshifumi Komoike, Toshitaka Nakamura, Hiroshi Ohtsu, Hirofumi Mukai
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Takuji Iwase, Shigehira Saji, Kotaro Iijima, Kenji Higaki, Shoichiro Ohtani, Yasuyuki Sato, Yasuo Hozumi, Yoshie Hasegawa, Yasuhiro Yanagita, Hiroyuki Takei, Maki Tanaka, Hideji Masuoka, Masahiko Tanabe, Chiyomi Egawa, Yoshifumi Komoike, Toshitaka Nakamura, Hiroshi Ohtsu, Hirofumi Mukai
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Takuji Iwase, Shigehira Saji, Kotaro Iijima, Kenji Higaki, Shoichiro Ohtani, Yasuyuki Sato, Yasuo Hozumi, Yoshie Hasegawa, Yasuhiro Yanagita, Hiroyuki Takei, Maki Tanaka, Hideji Masuoka, Masahiko Tanabe, Chiyomi Egawa, Yoshifumi Komoike, Toshitaka Nakamura, Hiroshi Ohtsu, Hirofumi Mukai
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Yasuaki Uemoto, Taro Yamanaka, Yuki Kataoka, Yoshitaka Wada, Yosuke Aoyama, Rika Kizawa, Takeshi Yamaguchi, Yuichiro Kikawa, Hirofumi Mukai, Naruto Taira
Efficacy of Telemedicine Using Videoconferencing Systems in Outpatient Care for Patients With Cancer: A Systematic Review and Meta-Analysis. JCO clinical cancer informatics 6 (2022)
Hirofumi Mukai, Yukari Uemura, Hiromitsu Akabane, Takanori Watanabe, Youngjin Park, Masato Takahashi, Yoshiaki Sagara, Reiki Nishimura, Tsutomu Takashima, Tomomi Fujisawa, Yasuo Hozumi, Takuya Kawahara
Anthracycline-containing regimens or taxane versus S-1 as first-line chemotherapy for metastatic breast cancer. British journal of cancer 125 (9) (2021)
Naruto Taira, Masataka Sawaki, Yukari Uemura, Tsuyoshi Saito, Shinichi Baba, Kokoro Kobayashi, Hiroaki Kawashima, Michiko Tsuneizumi, Noriko Sagawa, Hiroko Bando, Masato Takahashi, Miki Yamaguchi, Tsutomu Takashima, Takahiro Nakayama, Masahiro Kashiwaba, Toshiro Mizuno, Yutaka Yamamoto, Hiroji Iwata, Yasuo Ohashi, Hirofumi Mukai, Takuya Kawahara, null null
Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (22) (2021)
Hirofumi Mukai, Takeshi Yamaguchi, Masato Takahashi, Yasuo Hozumi, Tomomi Fujisawa, Shozo Ohsumi, Hiromitsu Akabane, Reiki Nishimura, Tsutomu Takashima, Youngjin Park, Yasuaki Sagara, Tatsuya Toyama, Shigeru Imoto, Toshiro Mizuno, Satoshi Yamashita, Satoshi Fujii, Yukari Uemura
Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study. British journal of cancer 122 (12) (2020)
Shinji Ohno, Hirofumi Mukai, Kazutaka Narui, Yasuo Hozumi, Yasuo Miyoshi, Hiroshi Yoshino, Hiroyoshi Doihara, Akihiko Suto, Motoshi Tamura, Takashi Morimoto, Hisamitsu Zaha, Takashi Chishima, Reiki Nishimura, Takashi Ishikawa, Yukari Uemura, Yasuo Ohashi
Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study. Breast cancer research and treatment 176 (3) (2019)